WO2006096614A3 - Angiogenic heparin binding peptide amphiphiles - Google Patents

Angiogenic heparin binding peptide amphiphiles Download PDF

Info

Publication number
WO2006096614A3
WO2006096614A3 PCT/US2006/007864 US2006007864W WO2006096614A3 WO 2006096614 A3 WO2006096614 A3 WO 2006096614A3 US 2006007864 W US2006007864 W US 2006007864W WO 2006096614 A3 WO2006096614 A3 WO 2006096614A3
Authority
WO
WIPO (PCT)
Prior art keywords
binding peptide
peptide amphiphiles
heparin binding
angiogenic heparin
angiogenic
Prior art date
Application number
PCT/US2006/007864
Other languages
French (fr)
Other versions
WO2006096614A2 (en
Inventor
Samuel I Stupp
James F Hulvat
Kanya Rajangam
Original Assignee
Univ Northwestern
Samuel I Stupp
James F Hulvat
Kanya Rajangam
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Northwestern, Samuel I Stupp, James F Hulvat, Kanya Rajangam filed Critical Univ Northwestern
Priority to CA002598251A priority Critical patent/CA2598251A1/en
Priority to AU2006220765A priority patent/AU2006220765A1/en
Priority to JP2007558319A priority patent/JP2008531733A/en
Priority to MX2007010771A priority patent/MX2007010771A/en
Priority to EP06737084A priority patent/EP1853917A4/en
Priority to NZ560649A priority patent/NZ560649A/en
Publication of WO2006096614A2 publication Critical patent/WO2006096614A2/en
Publication of WO2006096614A3 publication Critical patent/WO2006096614A3/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/10—Peptides having 12 to 20 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/54—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
    • A61K47/542—Carboxylic acids, e.g. a fatty acid or an amino acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof

Abstract

Peptide amphiphiles and related compositions comprising sulfated polysaccharides, such as but not limited to sulfated glycosaminoglycans, and methods of use relating to the encapsulation and/or controlled release of angiogenic growth factor(s).
PCT/US2006/007864 2005-03-04 2006-03-06 Angiogenic heparin binding peptide amphiphiles WO2006096614A2 (en)

Priority Applications (6)

Application Number Priority Date Filing Date Title
CA002598251A CA2598251A1 (en) 2005-03-04 2006-03-06 Angiogenic heparin binding peptide amphiphiles
AU2006220765A AU2006220765A1 (en) 2005-03-04 2006-03-06 Angiogenic heparin binding peptide amphiphiles
JP2007558319A JP2008531733A (en) 2005-03-04 2006-03-06 Angiogenic heparin-binding epitopes, peptide amphiphiles, self-assembling compositions, and related uses
MX2007010771A MX2007010771A (en) 2005-03-04 2006-03-06 Angiogenic heparin binding peptide amphiphiles.
EP06737084A EP1853917A4 (en) 2005-03-04 2006-03-06 Angiogenic heparin-binding peptide amphiphiles
NZ560649A NZ560649A (en) 2005-03-04 2006-03-06 Angiogenic heparin binding peptide amphiphiles, peptide amphiphiles, self-assembled composition and related methods of use

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US65850305P 2005-03-04 2005-03-04
US60/658,503 2005-03-04

Publications (2)

Publication Number Publication Date
WO2006096614A2 WO2006096614A2 (en) 2006-09-14
WO2006096614A3 true WO2006096614A3 (en) 2006-12-21

Family

ID=36953924

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2006/007864 WO2006096614A2 (en) 2005-03-04 2006-03-06 Angiogenic heparin binding peptide amphiphiles

Country Status (10)

Country Link
US (1) US7851445B2 (en)
EP (1) EP1853917A4 (en)
JP (1) JP2008531733A (en)
KR (1) KR20070108555A (en)
CN (1) CN101184995A (en)
AU (1) AU2006220765A1 (en)
CA (1) CA2598251A1 (en)
MX (1) MX2007010771A (en)
NZ (1) NZ560649A (en)
WO (1) WO2006096614A2 (en)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003054146A2 (en) 2001-11-14 2003-07-03 Northwestern University Self-assembly and mineralization of peptide-amphiphile nanofibers
WO2003070749A2 (en) * 2002-02-15 2003-08-28 Northwestern University Self-assembly of peptide-amphiphile nanofibers under physiological conditions
US9101687B2 (en) 2002-07-15 2015-08-11 University Of Leeds Beta sheet tapes ribbons in tissue engineering
US8586539B2 (en) 2002-07-15 2013-11-19 University Of Leeds Beta sheet tapes ribbons in tissue engineering
US7534761B1 (en) 2002-08-21 2009-05-19 North Western University Charged peptide-amphiphile solutions and self-assembled peptide nanofiber networks formed therefrom
US7554021B2 (en) 2002-11-12 2009-06-30 Northwestern University Composition and method for self-assembly and mineralization of peptide amphiphiles
AU2003298647A1 (en) 2002-11-14 2004-06-15 Claussen, Randal, C. Synthesis and self-assembly of abc triblock bola peptide
WO2004072104A2 (en) 2003-02-11 2004-08-26 Northwestern University Methods and materials for nanocrystalline surface coatings and attachment of peptide amphiphile nanofibers thereon
CN102225964A (en) * 2003-12-05 2011-10-26 西北大学 Self-assembling peptide amphiphiles and related methods for growth factor delivery
WO2005056576A2 (en) 2003-12-05 2005-06-23 Northwestern University Branched peptide amphiphiles, related epitope compounds and self assembled structures thereof
MX2007008826A (en) * 2005-01-21 2007-11-15 Univ Northwestern Methods and compositions for encapsulation of cells.
KR20070108555A (en) 2005-03-04 2007-11-12 노오쓰웨스턴 유니버시티 Angiogenic heparin binding peptide amphiphiles
US8834840B1 (en) 2006-10-04 2014-09-16 Northwestern University Magnetic resonance imaging of self-assembled biomaterial scaffolds
US8076295B2 (en) * 2007-04-17 2011-12-13 Nanotope, Inc. Peptide amphiphiles having improved solubility and methods of using same
WO2009075774A2 (en) * 2007-12-05 2009-06-18 Massachusetts Institute Of Technology Glycosaminoglycan-coated particles and uses thereof
DK2280720T3 (en) 2008-03-27 2019-06-11 Purdue Research Foundation COLLAGEN BINDING SYNTHETIC PEPTIDOGLYCANES, MANUFACTURING AND PROCEDURE FOR USE
KR20120012811A (en) * 2009-04-13 2012-02-10 노오쓰웨스턴 유니버시티 Novel peptide-based scaffolds for cartilage regeneration and methods for their use
KR101220162B1 (en) * 2009-07-02 2013-01-14 한양대학교 산학협력단 Arginine―based amphiphilic peptide micelle
US20110269231A1 (en) * 2010-04-22 2011-11-03 Wisconsin Alumni Research Foundation Proteoglycan-binding peptides that modulate stem cell behavior
GB201011602D0 (en) * 2010-07-09 2010-08-25 Univ London Pharmacy Delivery of hydrophilic peptides
KR102006036B1 (en) 2011-05-24 2019-07-31 시믹 아이피, 엘엘씨 Hyaluronic acid-binding synthetic peptidoglycans, preparation, and methods of use
US9169294B2 (en) * 2013-03-11 2015-10-27 Northwestern University Anti-angiogenic molecules, nanostructures and uses thereof
JP6603650B2 (en) 2013-03-15 2019-11-06 パーデュー・リサーチ・ファウンデーション Extracellular matrix-bound synthetic peptidoglycan
GB201306338D0 (en) 2013-04-08 2013-05-22 Univ Leeds Novel proteoglycans
WO2015048747A1 (en) 2013-09-30 2015-04-02 Northwestern University Targeted therapy for the prevention of restenosis in the cardiovascular system
US10772931B2 (en) 2014-04-25 2020-09-15 Purdue Research Foundation Collagen binding synthetic peptidoglycans for treatment of endothelial dysfunction
US20160159869A1 (en) 2014-12-09 2016-06-09 Northwestern University Bmp-2-binding peptide amphiphile nanofibers
US9238090B1 (en) 2014-12-24 2016-01-19 Fettech, Llc Tissue-based compositions
DE102015000363A1 (en) 2015-01-20 2016-07-21 Emc Microcollections Gmbh New modular functionalizable peptide hydrogels
US20170051016A1 (en) 2015-08-17 2017-02-23 Northwestern University Anti-inflammatory nanofibers
EP3362079B1 (en) 2015-10-14 2022-04-06 Northwestern University Nanofiber paste for growth factor delivery and bone regeneration
US10738294B2 (en) 2016-09-26 2020-08-11 Northwestern University Tissue factor (TF)—targeted nanotherapy
WO2018075885A1 (en) 2016-10-21 2018-04-26 Northwestern University Anti-microbial supramolecular structures
US10584146B2 (en) 2016-12-07 2020-03-10 Uchicago Argonne, Llc Heme peptide materials for anti-inflammatory regenerative nanobiomedicine
EP3648774A4 (en) 2017-07-07 2021-04-21 Symic IP, LLC Synthetic bioconjugates
US11964000B2 (en) 2020-04-10 2024-04-23 Northwestern University Cancer treatment methods using nanofiber stabilized growth factors
CN114933635B (en) 2021-08-29 2023-05-19 武汉夫图生物科技有限公司 Nano small peptide FH and application thereof in preparation of drugs for treating and preventing fundus vascular diseases
CN115010790B (en) 2021-08-29 2024-03-08 湖北烛照生物科技有限公司 Nanometer small peptide FG and application thereof in preparing medicament for treating and preventing fundus blood vessel diseases

Family Cites Families (78)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US513023A (en) * 1894-01-16 Thirds to moses b
US4554101A (en) * 1981-01-09 1985-11-19 New York Blood Center, Inc. Identification and preparation of epitopes on antigens and allergens on the basis of hydrophilicity
US5130123A (en) 1981-03-04 1992-07-14 The University Of Melbourne Dentifrice
US4930077A (en) * 1987-04-06 1990-05-29 Fan David P Information processing expert system for text analysis and predicting public opinion based information available to the public
US5128319A (en) * 1987-08-28 1992-07-07 Board Of Regents, The University Of Texas System Prophylaxis and therapy of acquired immunodeficiency syndrome
GB8812214D0 (en) * 1988-05-24 1988-06-29 Hoffmann La Roche Use of peptide from circumsporozoite protein of p falciparum as universally recognized t-cell epitope
JPH0399096A (en) 1989-09-11 1991-04-24 Agency Of Ind Science & Technol Length control of short fiber-type helical molecule associated form
DE4026978A1 (en) * 1990-08-25 1992-02-27 Bayer Ag Coated substrates for electro=optical applications, etc.
EP0585368B1 (en) * 1991-04-25 1997-08-06 Brown University Research Foundation Implantable biocompatible immunoisolatory vehicle for delivery of selected therapeutic products
WO1993022343A1 (en) 1992-05-01 1993-11-11 The Rockfeller University Multiple antigen peptide system having adjuvant properties and vaccines prepared therefrom
GB9215780D0 (en) 1992-07-24 1992-09-09 Univ London Pharmacy Peptide compounds
US5955343A (en) * 1992-12-28 1999-09-21 Massachusetts Institute Of Technology Stable macroscopic membranes formed by self-assembly of amphiphilic peptides and uses therefor
US5670483A (en) * 1992-12-28 1997-09-23 Massachusetts Insititute Of Technology Stable macroscopic membranes formed by self-assembly of amphiphilic peptides and uses therefor
SE9402531L (en) * 1994-07-19 1996-01-20 Medicarb Ab wound healing agent
US5843780A (en) * 1995-01-20 1998-12-01 Wisconsin Alumni Research Foundation Primate embryonic stem cells
US6410690B1 (en) * 1995-06-07 2002-06-25 Medarex, Inc. Therapeutic compounds comprised of anti-Fc receptor antibodies
ATE342295T1 (en) * 1995-07-28 2006-11-15 Genzyme Corp BIODEGRADABLE MULTIBLOKHYDROGENS AND THEIR USE AS CARRIERS FOR CONTROLLED RELEASE PHARMACOLOGICALLY ACTIVE MATERIALS AND TISSUE CONTACT MATERIALS
FR2739860B1 (en) 1995-10-17 1998-01-02 Coletica AMPHIPHILIC COMPLEXES, PROCESS FOR THEIR PREPARATION AND COMPOSITIONS CONTAINING THE SAME
SE9504347D0 (en) 1995-12-01 1995-12-01 Boerje Sellergren Surface modification technique
US6051272A (en) * 1996-03-15 2000-04-18 The Board Of Trustees Of The University Of Illinois Method for synthesizing organoapatites on to surgical metal alloys
US5733868A (en) * 1996-04-16 1998-03-31 Depuy Orthopaedics, Inc. Poly(amino acid) adhesive tissue grafts
US6085206A (en) * 1996-06-20 2000-07-04 Microsoft Corporation Method and system for verifying accuracy of spelling and grammatical composition of a document
US5993541A (en) * 1996-07-31 1999-11-30 Geo Centers Inc Process for nucleation of ceramics and product thereof
US6096863A (en) * 1996-08-23 2000-08-01 Regents Of The University Of Minnesota Self-assembling amphiphiles for construction of peptide secondary structures
US6458924B2 (en) * 1996-08-30 2002-10-01 Novo Nordisk A/S Derivatives of GLP-1 analogs
CA2278106C (en) * 1997-01-22 2005-04-12 Board Of Regents, The University Of Texas System Tissue factor methods and compositions for coagulation and tumor treatment
US6331406B1 (en) * 1997-03-31 2001-12-18 The John Hopkins University School Of Medicine Human enbryonic germ cell and methods of use
US6181909B1 (en) * 1997-07-22 2001-01-30 Educational Testing Service System and method for computer-based automatic essay scoring
US6269368B1 (en) * 1997-10-17 2001-07-31 Textwise Llc Information retrieval using dynamic evidence combination
AU1615599A (en) * 1997-12-02 1999-06-16 Zen Bio, Inc. Differentiation of adipose stromal cells into osteoblasts and uses thereof
GB9801061D0 (en) * 1998-01-20 1998-03-18 Univ Nottingham Patterning technique
SE519827C2 (en) * 1998-03-30 2003-04-15 Viranative Ab Nutritional medium containing methionine and its use
US6548048B1 (en) * 1998-04-28 2003-04-15 Amersham Health As Lipopeptide stabilized microbubbles as diagnostic/therapeutic agents
GB9809084D0 (en) 1998-04-28 1998-06-24 Nycomed Imaging As Improvements in or relating to diagnostic/therapeutic agents
US7601685B2 (en) * 1998-08-27 2009-10-13 Eidgenossische Technische Hochschule Zurich Growth factor modified protein matrices for tissue engineering
AU758178B2 (en) 1998-09-04 2003-03-20 Scios Inc. Hydrogel compositions for the controlled release administration of growth factors
CA2359318C (en) 1999-02-01 2009-06-30 Donald Elbert Biomaterials formed by nucleophilic addition reaction to conjugated unsaturated groups
WO2000045831A1 (en) * 1999-02-02 2000-08-10 Thomas Jefferson University Peptides modulating activities of heparin, other glycosaminoglycans or proteoglycans
EP1159404A2 (en) 1999-03-02 2001-12-05 University of Massachusetts, a Public Institution of Higher Education of The Commonwealth of Massachusetts, Embryonic or stem-like cell lines produced by cross species nuclear transplantation
US6473730B1 (en) * 1999-04-12 2002-10-29 The Trustees Of Columbia University In The City Of New York Method and system for topical segmentation, segment significance and segment function
ES2255257T3 (en) 1999-04-22 2006-06-16 Eidgenossische Technische Hochschule (Eth) CONTROLLED RELEASE OF GROWTH FACTORS FROM MATRICES CONTAINING HEPARINE.
US20090087878A9 (en) * 1999-05-06 2009-04-02 La Rosa Thomas J Nucleic acid molecules associated with plants
JP2003503071A (en) 1999-06-30 2003-01-28 アドバンスド セル テクノロジー、インコーポレイテッド Cytoplasmic transfer to dedifferentiated recipient cells
US6444723B1 (en) * 1999-11-10 2002-09-03 The United States Of America As Represented By The Secretary Of Commerce Crosslinked micellar gel composition
US20030050231A1 (en) * 2000-01-31 2003-03-13 Rosen Craig A. Nucleic acids, proteins, and antibodies
CA2395398A1 (en) 2000-01-31 2001-08-02 Human Genome Sciences, Inc. Nucleic acids, proteins, and antibodies
US6689165B2 (en) * 2000-03-31 2004-02-10 Board Of Supervisors Of Louisana State University And Agricultural And Mechanical College Surface modifications for enhanced epithelialization
BR0110679A (en) * 2000-04-28 2004-04-20 Univ Dublin Amphophilic macrocyclic derivatives and their analogs
AU2001261505A1 (en) * 2000-05-11 2001-11-20 University Of Southern California Machine translation techniques
JP4070605B2 (en) * 2000-10-19 2008-04-02 アイトゲノッシスシェ・テヒニッシュ・ホーホシューレ・ツューリヒ Block copolymers for multifunctional self-assembled systems
MXPA03006566A (en) * 2001-01-23 2004-10-15 Educational Testing Service Methods for automated essay analysis.
ATE419333T1 (en) 2001-02-06 2009-01-15 Massachusetts Inst Technology PEPTIDE STRUCTURE ENCAPSULATION OF TISSUE CELLS AND USES THEREOF
US7449180B2 (en) * 2001-02-06 2008-11-11 John Kisiday Macroscopic scaffold containing amphiphilic peptides encapsulating cells
WO2003006043A1 (en) * 2001-07-10 2003-01-23 Massachusetts Institute Of Technology Surfactant peptide nanostructures, and uses thereof
AU2002361601A1 (en) 2001-11-06 2003-05-19 Mark C. Fishman Stem and progenitor cell capture for tissue regeneration
WO2003054146A2 (en) 2001-11-14 2003-07-03 Northwestern University Self-assembly and mineralization of peptide-amphiphile nanofibers
WO2003070749A2 (en) * 2002-02-15 2003-08-28 Northwestern University Self-assembly of peptide-amphiphile nanofibers under physiological conditions
WO2003084980A2 (en) 2002-04-02 2003-10-16 Northwestern University Peptide amphiphile solutions and self assembled peptide nanofiber networks
WO2003090255A2 (en) 2002-04-18 2003-10-30 Northwestern University Encapsulation of nanotubes via self-assembled nanostructures
WO2004003561A1 (en) 2002-06-27 2004-01-08 Northwestern University Peptide rod amphiphiles and self-assembly of same
WO2004024778A2 (en) 2002-07-23 2004-03-25 Northwestern University Self-assembled hybrid compositions and method of making, using and ordering same
US7534761B1 (en) * 2002-08-21 2009-05-19 North Western University Charged peptide-amphiphile solutions and self-assembled peptide nanofiber networks formed therefrom
AU2003304152A1 (en) * 2002-09-23 2005-01-21 Northwestern University Self-assembled peptide-amphiphiles and self-assembled peptide nanofiber networks presenting multiple signals
US7135027B2 (en) * 2002-10-04 2006-11-14 Baxter International, Inc. Devices and methods for mixing and extruding medically useful compositions
WO2005003292A2 (en) 2002-11-12 2005-01-13 Northwestern University Composition and method for self-assembly and mineralization of peptide amphiphiles
US7554021B2 (en) * 2002-11-12 2009-06-30 Northwestern University Composition and method for self-assembly and mineralization of peptide amphiphiles
AU2003298647A1 (en) 2002-11-14 2004-06-15 Claussen, Randal, C. Synthesis and self-assembly of abc triblock bola peptide
WO2004072104A2 (en) 2003-02-11 2004-08-26 Northwestern University Methods and materials for nanocrystalline surface coatings and attachment of peptide amphiphile nanofibers thereon
US7259140B2 (en) * 2003-03-28 2007-08-21 Thomas Jefferson University Heparin-binding peptides and uses thereof
US20070141101A1 (en) * 2003-04-10 2007-06-21 The Trustees Of Boston University Method for stimulating angiogenesis and wound healing
WO2005056576A2 (en) 2003-12-05 2005-06-23 Northwestern University Branched peptide amphiphiles, related epitope compounds and self assembled structures thereof
CN102225964A (en) * 2003-12-05 2011-10-26 西北大学 Self-assembling peptide amphiphiles and related methods for growth factor delivery
US20050214257A1 (en) * 2003-12-23 2005-09-29 Northwestern University Compositions and methods for controlling stem cell and tumor cell differentiation, growth, and formation
MX2007008826A (en) * 2005-01-21 2007-11-15 Univ Northwestern Methods and compositions for encapsulation of cells.
WO2006079019A2 (en) * 2005-01-21 2006-07-27 Alza Corporation Therapeutic peptide formulations for coating microneedles with improved stabitity containing at least one counterion
KR20070108555A (en) 2005-03-04 2007-11-12 노오쓰웨스턴 유니버시티 Angiogenic heparin binding peptide amphiphiles
US8114834B2 (en) * 2006-11-09 2012-02-14 Northwestern University Self-assembling peptide amphiphiles
US8114835B2 (en) * 2006-11-09 2012-02-14 Northwestern University Self-assembling peptide amphiphiles for tissue engineering

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
BULL S.R. ET AL.: "Self-Assembled Peptide Amphiphile Nanofibers Conjugated to MRI Contrast Agents", NANO LETTERS, vol. 5, no. 1, December 2004 (2004-12-01), pages 1 - 4, XP003004949 *

Also Published As

Publication number Publication date
CN101184995A (en) 2008-05-21
AU2006220765A1 (en) 2006-09-14
WO2006096614A2 (en) 2006-09-14
CA2598251A1 (en) 2006-09-14
EP1853917A2 (en) 2007-11-14
EP1853917A4 (en) 2008-09-10
KR20070108555A (en) 2007-11-12
JP2008531733A (en) 2008-08-14
US7851445B2 (en) 2010-12-14
US20070277250A1 (en) 2007-11-29
NZ560649A (en) 2011-03-31
MX2007010771A (en) 2008-03-10

Similar Documents

Publication Publication Date Title
WO2006096614A3 (en) Angiogenic heparin binding peptide amphiphiles
WO2009074735A3 (en) Use of a novel natural agent in cosmetic compositions
WO2006050477A3 (en) Anti-microbial compositions and methods of making and using the same
MX2007012623A (en) Long-chain inulin.
WO2006073968A3 (en) Derivatized 3,4-alkylenedioxythiophene monomers, methods of making them, and use thereof
WO2008036932A3 (en) Compositions and methods comprising boswellia species
IL213718A (en) Immunogenic composition comprising at least two different saccharides conjugated separately to the same type of carrier protein and vaccine comprising such composition
WO2008147867A3 (en) Cross-linked collagen and uses thereof
WO2007038629A3 (en) Dry platelet composition
WO2009052492A3 (en) Demineralized bone matrix compositions and methods
WO2007086001A3 (en) Novel pyridine derivatives
WO2008034013A3 (en) Medical devices and methods of making the same
WO2008083157A3 (en) Altering pgc-1alapha, ampk, fiaf, or the gastrointestinal microbiota as a means to modulate body fat and/or weight loss in a subject
WO2010077740A3 (en) Novel antiviral compounds, compositions, and methods of use
WO2005079396A3 (en) O,o'-amidomalonate and n,o-amidomalonate platinum complexes
WO2009118253A3 (en) Hair styling composition
WO2007144779A3 (en) Compositions comprising porphyra and methods of making and using thereof
WO2009085889A3 (en) Compositions and methods for reducing or preventing water loss from the skin
WO2006118884A3 (en) Drug delivery devices and related components, systems and methods
WO2006130703A3 (en) Modified release formulations of anti-irritability drugs
EP1828305A4 (en) Low loss prepregs, compositions useful for the preparation thereof and uses therefor
WO2004091645A3 (en) Composition comprising rosmarinic acid, borneol and ginsenoside
WO2007057873A3 (en) Novel compositions to improve gut health and animal performance and methods of making the same
WO2005070183A3 (en) Ice cream and ice cream formulations containing maltitol
MX2010003362A (en) Natural preservatives and antimicrobial agents.

Legal Events

Date Code Title Description
WWE Wipo information: entry into national phase

Ref document number: 200680006909.1

Country of ref document: CN

121 Ep: the epo has been informed by wipo that ep was designated in this application
WWE Wipo information: entry into national phase

Ref document number: 560649

Country of ref document: NZ

WWE Wipo information: entry into national phase

Ref document number: 2006220765

Country of ref document: AU

ENP Entry into the national phase

Ref document number: 2598251

Country of ref document: CA

WWE Wipo information: entry into national phase

Ref document number: MX/a/2007/010771

Country of ref document: MX

Ref document number: 2007558319

Country of ref document: JP

WWE Wipo information: entry into national phase

Ref document number: 3845/CHENP/2007

Country of ref document: IN

NENP Non-entry into the national phase

Ref country code: DE

WWE Wipo information: entry into national phase

Ref document number: 2006737084

Country of ref document: EP

ENP Entry into the national phase

Ref document number: 2006220765

Country of ref document: AU

Date of ref document: 20060306

Kind code of ref document: A

WWE Wipo information: entry into national phase

Ref document number: 1020077021897

Country of ref document: KR

NENP Non-entry into the national phase

Ref country code: RU